WebSEER Program Coding Manual. Hematopoietic Project. Solid Tumor Rules. Tools & Software. Glossary for Registrars. SEER*Rx - Drug Database. ... Darzalex Faspro … WebYou can ask your pharmacist or healthcare provider for information about DARZALEX FASPRO ® that is written for health professionals. Active ingredient: daratumumab and …
ICD-10 Codes Janssen CarePath for Healthcare …
WebJanssen CarePath for Patients and Caregivers WebDARZALEX FASPRO ® (daratumumab and hyaluronidase-fihj) is indicated for the treatment of adult patients with multiple myeloma: In combination with bortezomib, melphalan, and prednisone in newly diagnosed patients who are ineligible for … hope mickelson legacy
HIGHLIGHTS OF PRESCRIBING INFORMATION …
WebJan 15, 2024 · January 15, 2024 (HORSHAM, Pa.)– The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the U.S. Food and Drug Administration (FDA) approval of DARZALEX FASPRO ® (daratumumab and hyaluronidase-fihj), a subcutaneous formulation of daratumumab, in combination with bortezomib, … WebApr 3, 2024 · CONTRAINDICATIONS. DARZALEX FASPRO ® is contraindicated in patients with a history of severe hypersensitivity to daratumumab, hyaluronidase, or any of the components of the formulation.. WARNINGS AND PRECAUTIONS. Hypersensitivity and Other Administration Reactions. Both systemic administration-related reactions, including … WebNo dose reductions of DARZALEX FASPRO are recommended. Consider withholding DARZALEX FASPRO to allow recovery of blood cell counts in the event of … hope michigan map